Viewing Study NCT03928704


Ignite Creation Date: 2025-12-24 @ 9:12 PM
Ignite Modification Date: 2026-02-21 @ 1:20 AM
Study NCT ID: NCT03928704
Status: COMPLETED
Last Update Posted: 2025-12-24
First Post: 2019-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Nonradiographic Axial Spondyloarthritis
Sponsor: UCB Biopharma SRL
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-04-25
Start Date Type: ACTUAL
Primary Completion Date: 2022-06-29
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04-17
Completion Date Type: ACTUAL
First Submit Date: 2019-04-23
First Submit QC Date: None
Study First Post Date: 2019-04-26
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-10-18
Results First Submit QC Date: None
Results First Post Date: 2024-11-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2023-06-29
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2025-12-05
Last Update Post Date: 2025-12-24
Last Update Post Date Type: ACTUAL